Parnassus Investments
TXG icon

Parnassus Investments’s 10x Genomics TXG Stock Holding History

Parnassus Investments’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-93,160
Closed -$7.09M – 134
2022
Q1 		$7.09M Hold
93,160
– – 0.01% 130
2021
Q4 		$13.9M Hold
93,160
– – 0.03% 120
2021
Q3 		$13.6M Hold
93,160
– – 0.03% 120
2021
Q2 		$18.2M Hold
93,160
– – 0.04% 116
2021
Q1 		$16.9M Buy
93,160
+21,511
+30% +$3.71M 0.04% 116
2020
Q4 		$10.1M Buy
+71,649
New +$10.4M 0.03% 108

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
SIM
SRS Investment Management New York $10.8B AUM 34.05% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Parnassus Investments's TXG Position: Q2 2022 in Review

Parnassus Investments sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 93,160 shares — an estimated $7.09M sold.

Parnassus Investments first reported a position in TXG in Q4 2020 and held it in 6 quarters. The position peaked at $18.2M in Q2 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

  • Parnassus Investments reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
  • Parnassus Investments sold 93,160 10x Genomics shares in Q2 2022, an estimated $7.09M.
  • Parnassus Investments first reported a position in 10x Genomics in Q4 2020 and held it in 6 quarters.
  • Parnassus Investments's 10x Genomics position peaked at $18.2M in Q2 2021.
  • 254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Parnassus Investments's 13F filing for Q2 2022, filed 5 Aug 2022.